Statement Of Financial Position [Abstract]

OSE Immunotherapeutics - Filing #831399

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment
464,000 EUR
743,000 EUR
Intangible assets other than goodwill
46 401 EUR
48 784 EUR
Deferred tax assets
195,000 EUR
182,000 EUR
Non-current assets
51 576 EUR
54 581 EUR
Current assets [abstract]
Cash and cash equivalents
18 672 EUR
25 620 EUR
33 579 EUR
Current assets
30 478 EUR
37 200 EUR
Assets
82 054 EUR
91 781 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
4 330 EUR
3 705 EUR
Share premium
76 643 EUR
65 611 EUR
Treasury shares
408,000 EUR
549,000 EUR
Equity
76 643 EUR
4 330 EUR
309,000 EUR
22 975 EUR
408,000 EUR
57 282 EUR
32 658 EUR
65 611 EUR
549,000 EUR
3 705 EUR
220,000 EUR
35 890 EUR
160,000 EUR
47 890 EUR
21 111 EUR
65 605 EUR
150,000 EUR
3 705 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current provisions [abstract]
Non-current provisions
429,000 EUR
524,000 EUR
Deferred tax liabilities
1 311 EUR
1 514 EUR
Non-current liabilities
40 280 EUR
42 856 EUR
Current liabilities [abstract]
Current tax liabilities, current
20,000 EUR
21,000 EUR
Current liabilities
18 799 EUR
16 268 EUR
Equity and liabilities
82 054 EUR
91 781 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.